Medical Cost of Colorectal Cancer Services in Serbia Between 2014 and 2017: National Data Report.
作者信息
Vekic Berislav, Dragojevic-Simic Viktorija, Jakovljevic Mihajlo, Pilipovic Filip, Simic Radoje, Zivic Rastko, Radovanovic Dragce, Rancic Nemanja
机构信息
Department of Surgery, Clinical Centre "Dr. Dragisa Misovic", Belgrade, Serbia.
Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.
出版信息
Front Pharmacol. 2019 May 15;10:526. doi: 10.3389/fphar.2019.00526. eCollection 2019.
Abstract
摘要
相似文献
1
Medical Cost of Colorectal Cancer Services in Serbia Between 2014 and 2017: National Data Report.
Front Pharmacol. 2019 May 15;10:526. doi: 10.3389/fphar.2019.00526. eCollection 2019.
2
Medical cost of breast cancer services in Serbia between 2010 and 2019: national data report.
Front Public Health. 2024 Mar 28;12:1378886. doi: 10.3389/fpubh.2024.1378886. eCollection 2024.
3
Colorectal cancer mortality trends in Serbia during 1991-2010: an age-period-cohort analysis and a joinpoint regression analysis.
Chin J Cancer. 2016 Jun 22;35(1):55. doi: 10.1186/s40880-016-0118-y.
4
Organized colorectal cancer screening in Serbia - the first round within 2013-2014.
Vojnosanit Pregl. 2016 Apr;73(4):360-7. doi: 10.2298/VSP150421113B.
5
Radiation therapy remains the key cost driver of oncology inpatient treatment.
J Med Econ. 2015 Jan;18(1):29-36. doi: 10.3111/13696998.2014.971162. Epub 2014 Oct 10.
6
[Assessment of diabetes mellitus type 2 treatment costs in the Republic of Serbia].
Vojnosanit Pregl. 2009 Apr;66(4):271-6. doi: 10.2298/vsp0904271b.
7
Reimbursement of targeted cancer therapies within 3 different European health care systems.
Clin Ther. 2015 Feb 1;37(2):474-80. doi: 10.1016/j.clinthera.2014.12.005. Epub 2015 Jan 28.
8
[Assessment of required resources for implementation of national breast cancer screening program in Serbia].
Srp Arh Celok Lek. 2014 Jan-Feb;142(1-2):59-66. doi: 10.2298/sarh1402059m.
9
[Analysis of mortality in cancer of the large intestine in a cohort group in Serbia from 1971 to 1996].
Srp Arh Celok Lek. 2002 May-Jun;130(5-6):173-7. doi: 10.2298/sarh0206173g.
10
Five-year survival and costs of care in metastatic colorectal cancer: conventional versus monoclonal antibody-based treatment protocols.
Expert Rev Anticancer Ther. 2015;15(8):963-70. doi: 10.1586/14737140.2015.1059280. Epub 2015 Jun 18.
引用本文的文献
1
Medical treatment cost for Chinese inpatients with colorectal cancer by sites.
Front Public Health. 2025 Jun 11;13:1605887. doi: 10.3389/fpubh.2025.1605887. eCollection 2025.
2
Two Decades of Progress in Personalized Medicine of Colorectal Cancer in Serbia-Insights from the Institute for Oncology and Radiology of Serbia.
Biomedicines. 2024 Oct 8;12(10):2278. doi: 10.3390/biomedicines12102278.
3
Availability and Access to Orphan Drugs for Rare Cancers in Bulgaria: Analysis of Delays and Public Expenditures.
Cancers (Basel). 2024 Apr 12;16(8):1489. doi: 10.3390/cancers16081489.
4
Resource Oriented Decision Making for Treatment of Metastatic Colorectal Cancer (mCRC) in a Lower-Middle Income Country: Egyptian Foundation of Medical Sciences (EFMS) Consensus Recommendations 2020.
Cancer Manag Res. 2022 Feb 28;14:821-842. doi: 10.2147/CMAR.S340030. eCollection 2022.
5
A Correlation Study of the Colorectal Cancer Statistics and Economic Indicators in Selected Balkan Countries.
Front Public Health. 2020 Feb 18;8:29. doi: 10.3389/fpubh.2020.00029. eCollection 2020.
本文引用的文献
1
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
2
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018.
Eur J Cancer. 2018 Nov;103:356-387. doi: 10.1016/j.ejca.2018.07.005. Epub 2018 Aug 9.
3
Radiology Services Costs and Utilization Patterns Estimates in Southeastern Europe-A Retrospective Analysis from Serbia.
Value Health Reg Issues. 2013 Sep-Oct;2(2):218-225. doi: 10.1016/j.vhri.2013.07.002. Epub 2013 Sep 13.
4
Pricing of monoclonal antibody therapies: higher if used for cancer?
Am J Manag Care. 2018 Feb;24(2):109-112.
5
Colorectal cancer-global burden, trends, and geographical variations.
J Surg Oncol. 2017 Apr;115(5):619-630. doi: 10.1002/jso.24578. Epub 2017 Feb 13.
6
Worldwide burden of colorectal cancer: a review.
Updates Surg. 2016 Mar;68(1):7-11. doi: 10.1007/s13304-016-0359-y. Epub 2016 Apr 11.
7
Five-year survival and costs of care in metastatic colorectal cancer: conventional versus monoclonal antibody-based treatment protocols.
Expert Rev Anticancer Ther. 2015;15(8):963-70. doi: 10.1586/14737140.2015.1059280. Epub 2015 Jun 18.
8
End-of-life costs of medical care for advanced stage cancer patients.
Vojnosanit Pregl. 2015 Apr;72(4):334-41. doi: 10.2298/vsp1504334k.
9
10
Economic burden of cancer across the European Union: a population-based cost analysis.
Lancet Oncol. 2013 Nov;14(12):1165-74. doi: 10.1016/S1470-2045(13)70442-X. Epub 2013 Oct 14.
Zotero 插件